GeoVax's COVID-19 Vaccine Study Ended by Funding Agency; Shares Fall

MT Newswires Live

04/16

GeoVax Labs (GOVX) said late Monday Advanced Technology International notified the company to stop work on its phase 2b study to evaluate the GEO-CM04S1 COVID-19 vaccine.

Advanced Technology is the Rapid Response Partnership Vehicle's consortium management firm funded by the Biomedical Advanced Research and Development Authority of the US Department of Health and Human Services, according to its regulatory filing.

The notice indicated that BARDA decided to terminate the contract for convenience to the government, the filing said.

Shares of the company were down over 21% in Tuesday trading.

Price: 0.84, Change: -0.23, Percent Change: -21.50

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2527644764"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2527644764\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2527644764?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-16 00:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2527644764","market":"nz","top_or_hot":-1,"title":"GeoVax's COVID-19 Vaccine Study Ended by Funding Agency; Shares Fall","media":"MT Newswires Live","content":"<html><body><p> GeoVax Labs (GOVX) said late Monday Advanced Technology International notified the company to stop work on its phase 2b study to evaluate the GEO-CM04S1 COVID-19 vaccine.</p><p>Advanced Technology is the Rapid Response Partnership Vehicle's consortium management firm funded by the Biomedical Advanced Research and Development Authority of the US Department of Health and Human Services, according to its regulatory filing.</p><p>The notice indicated that BARDA decided to terminate the contract for convenience to the government, the filing said.</p><p>Shares of the company were down over 21% in Tuesday trading.</p><p>Price: 0.84, Change: -0.23, Percent Change: -21.50</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GeoVax's COVID-19 Vaccine Study Ended by Funding Agency; Shares Fall</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGeoVax's COVID-19 Vaccine Study Ended by Funding Agency; Shares Fall\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-04-16 00:12</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> GeoVax Labs (GOVX) said late Monday Advanced Technology International notified the company to stop work on its phase 2b study to evaluate the GEO-CM04S1 COVID-19 vaccine.</p><p>Advanced Technology is the Rapid Response Partnership Vehicle's consortium management firm funded by the Biomedical Advanced Research and Development Authority of the US Department of Health and Human Services, according to its regulatory filing.</p><p>The notice indicated that BARDA decided to terminate the contract for convenience to the government, the filing said.</p><p>Shares of the company were down over 21% in Tuesday trading.</p><p>Price: 0.84, Change: -0.23, Percent Change: -21.50</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4583","symbol_name":"猴痘概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2527644764","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2527644764","pubTimestamp":1744733524,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"GeoVax Labs  said late Monday Advanced Technology International notified the company to stop work on its phase 2b study to evaluate the GEO-CM04S1 COVID-19 vaccine.Advanced Technology is the Rapid Response Partnership Vehicle's consortium management firm funded by the Biomedical Advanced Research and Development Authority of the US Department of Health and Human Services, according to its regulatory filing.The notice indicated that BARDA decided to terminate the contract for convenience to the government, the filing said.Shares of the company were down over 21% in Tuesday trading.Price: 0.84, Change: -0.23, Percent Change: -21.50","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4583":"猴痘概念","GOVX":"GeoVax Labs Inc","BK4139":"生物科技","BNTX":"BioNTech SE"},"translate_title":"GeoVax的新冠肺炎疫苗研究被资助机构终止；股价下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GOVX":0.9,"BNTX":1},"content_text":"GeoVax Labs (GOVX) said late Monday Advanced Technology International notified the company to stop work on its phase 2b study to evaluate the GEO-CM04S1 COVID-19 vaccine.Advanced Technology is the Rapid Response Partnership Vehicle's consortium management firm funded by the Biomedical Advanced Research and Development Authority of the US Department of Health and Human Services, according to its regulatory filing.The notice indicated that BARDA decided to terminate the contract for convenience to the government, the filing said.Shares of the company were down over 21% in Tuesday trading.Price: 0.84, Change: -0.23, Percent Change: -21.50","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}